The largest database of trusted experimental protocols

8 protocols using cd19 alexa fluor 700

1

Multicolor Flow Cytometry Panel

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following anti-human antibodies were used for staining: CD68-FITC, CD14-PercP-Cy5.5, HLA-DR-APC, CD15-PE-Cy7, CD11b-PErcP-Cy5.5, CD163-BV421, CD14-APC, HLA-DR-PE, CD33-BV421 and PD-L1-BV421 purchased from Biolegend (San Diego, CA), CD11b-PE, CD3-Alexa Fluor 700, CD19-Alexa Fluor 700, CD19-Alexa Fluor 700, CD163-Alexa Fluor 647, CD16-PE-Cy7, CD3-PE, CD19-PE and CD56-PE purchased from BD Biosciences (San Jose, CA), CD14-PE-TR and CD16 PE-TR purchased from Life Technologies (Carlsbad, CA) and CD86-FITC purchased from R&D systems (Minneapolis, MN). CD32-a-FITC Ab was purchased from Stemcell technologies, (Vancouver, Canada). CD-32-B (F-4) was purchased from Santa Cruz Biotechnology, Santa Cruz, CA, and secondary Ab anti-mouse F(ab’)2 was purchased from Thermo fisher scientific (MA, USA).
Intracellular staining of CD68 was performed as follows: PBMC were stained with surface marker antibodies, fixed with fixation/permeabilization buffer (eBioscience), washed, and stained for intracellular antigens in 1X permeabilization buffer. Cells were analyzed on an LSR Fortessa (BD) flow cytometer, and data analyzed using Flow Jo (Treestar, Ashland, OR). Dead cells were excluded based on viability dye staining (Zombie Aqua Fixable Viability Dye, Biolegend).
+ Open protocol
+ Expand
2

Comprehensive B Cell Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was used to follow changes in classical B cell immunophenotype markers (CD19, IgD, IgM, and CD27) as well as those involved in energy pathways including CD24, CD39, CD73, and CD38 throughout in vitro culture. B cell numbers, B cell growth (total mass), and viability were also calculated using flow cytometry. Briefly, PBMCs or B cells were stained for 20 min with fluorescent conjugates of monoclonal antibodies to CD19-Alexa Fluor 700, IgD-BV421, and IgM-BV605 (BD Biosciences, San Jose, CA, USA), CD27-APC and CD24-APC eFluor780 (eBioscience, San Diego, CA, USA), CD39-FITC, CD73-PE, and CD38-PerCP.Cy5.5 (Biolegend, San Diego, CA, USA), and a viability marker (LIVE/DEAD™ Fixable aqua dead cell stain, ThermoFisher Scientific, Waltham, MA, USA). The cells were washed and resuspended in PBS and acquired within 24 h on a BD LSR FortessaTMX-20. Total mass was calculated by combining the mass of debris, dead cells, and live cells in each culture well using the following formula: (FSC × mean number viable + FSC × mean number dead + FSC × mean number debris). Compensation beads (BD, Biosciences, San Jose, CA, USA) were used to optimize the fluorescence compensation settings for multicolor flow cytometric analysis. A minimum of 100,000 events in the lymphocyte gate was collected.
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMC were thawed in warm media, washed twice and stained with three separate antihuman antibody cocktails containing: (1 ) anti-CD3 AmCyan, CD4 Pacific Blue, CD8 APCH7, CD28 APC; (2 ) CD3 AmCyan, CD4 Pacific Blue, CD8 APCH7, CD27 PE, CD45RA PE-Cy5; (3 (link)) CD3 AmCyan, CD19 Alexa Fluor700, CD56 PE, CD33 PE-Cy7, TCR APC, all reagents from BD Biosciences. Additional information for these antibodies can be found on ImmPort (https://immport.niaid.nih.gov/) under accession number SDY212. Incubation with antibodies was performed for 40 min at 4ºC. Cells were washed with FACS buffer (PBS supplemented with 2% FBS and 0.1% Na Azide), and resuspended in 200 µL FACS buffer. Data was collected using DIVA software in an LRSII instrument (BD Biosciences). Analysis was performed using FlowJo 8.8.6 by gating on live cells based on forward vs side scatter profiles, then using double gating for singlet discrimination, followed by cell subset-specific gating.
+ Open protocol
+ Expand
4

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following anti-human mAbs were used for staining: HLA-DR-APC, CD11b-PErCP-Cy5.5, CD163-BV421, CD33-BV421, CD8-APC, PD-1-PE-Cy7, Tim-3-BV421, TIGIT-APC, CD27-Alexa Fluor 700, LAP-BV421, FoxP3-PerCP-Cy5.5 and PD-L1-PE purchased from Biolegend (San Diego, CA); CD11b-PE, CD1c-APC-Cy7, CD141-BV711, CD4-PerCP-Cy5.5, CD56-Alexa Fluor 700, CD3-Alexa Fluor 700, CD19-Alexa Fluor 700, CD16-PE-Cy7 , HLA-A2-APC-H7, CD73-PE, purchased from BD Biosciences (San Jose, CA); CD14-PE-TR purchased from Life Technologies (Carlsbad, CA); CD86-FITC purchased from R&D Systems (Minneapolis, MN); CTLA-4-FITC purchased from Ancell (Bayport, MN); and the PE-labeled HLA-A*0201-EGFR853-861 tetramer obtained from the Tetramer Facility of the National Institute of Allergy and Infectious Disease (Atlanta, GA).
Intracellular staining of FoxP3 was performed as follows: PBL or TIL were stained with surface marker antibodies, fixed with fixation/permeabilization buffer (eBioscience), washed, and stained for intracellular antigens in 1X permeabilization buffer. Cells were analyzed on an LSR Fortessa (BD) flow cytometer, and data analyzed using Flow Jo (Treestar, Ashland, OR). Dead cells were excluded based on viability dye staining (Zombie Aqua Fixable Viability Dye, Biolegend).
+ Open protocol
+ Expand
5

Phenotypic Analysis of Stimulated B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
After 4- and 7-days of CpG stimulation, PBMC were harvested from the culture plates and washed by centrifugation at 1200 rpm for 5 minutes at room temperature (RT) in wash buffer (2% FBS in PBS). To identify B cell subsets, single-cell suspensions were stained on day 0 and after 4–7 days of stimulation with CpG or incubation with IL-2 alone with the appropriate combination of the following directly conjugated monoclonal antibodies (MoAb): CD19-Alexa Fluor 700 (1∶90 dilution; BD Biosciences, San Diego, CA, USA), CD38-PECy7 (1∶90 dilution; BD Biosciences), CD24-FITC (1∶10 dilution, BD Biosciences), CD27-PE (1∶20 dilution; BD Biosciences) and IgM-Alexa Fluor 647 (1∶400 dilution; Jackson ImmunoResearch, West Baltimore, Pike, PA, USA). The cells were incubated for 20 minutes in the dark at 4°C. After labeling, the cells were washed by centrifugation at 1200 rpm for 5 minutes at 4°C in wash buffer. Data were acquired on a FACSCanto II. Flow cytometry profiles were analyzed using FACSDiva software (BD Biosciences, San Jose, CA, USA). Dead cells were excluded from the analysis by side/forward scatter gating. A minimum of fifty thousand gated events on living cells were collected per data set.
+ Open protocol
+ Expand
6

Multiparametric Flow Cytometry Analysis of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were resuspended in PBS, containing 0.5% w/v BSA and 0.01% sodium azide. PBMCs were incubated with saturating concentrations of fluorescently labeled conjugated mAbs. Analysis of cells was performed using a FACSCanto‐II flowcytometer and FlowJo software (version 9.1 and 10) and for the methods of flow cytometry we adhered to the ‘Guidelines for the use of flow cytometry and cell sorting in immunological studies’ 38. The following mAbs were used for flow cytometry: CD3 Alexa Fluor 700 [557943], CD4 PE‐Cy7 [348809], CD8 PerCP‐Cy5.5 [341050], CD19 Alexa Fluor 700 [557921], CD19 PerCP‐Cy 5.5 [332780], CD20 APC‐H7 [641414], CD20 PerCP‐Cy5.5 [332781], CD25 APC [340907], CD27 APC [337169], CD38 PE [345806], CD38 PE‐Cy7 [335825], HLA‐DR FITC [347400], and IgD PE [555779] from BD (San Jose, USA); CD3 Alexa 700 [56‐0038‐41], CD19 Alexa Fluor 700 [56‐0199‐42], and CD27 APC‐eFluor 780 [47‐0279‐42] from eBioscience (San Diego, USA); and CD27 FITC [M1764] from Sanquin (Amsterdam, the Netherlands). To assess lymphocyte viability TO‐PRO‐3 iodide [T3605] was used (Thermo Fisher Scientific, Massachusetts, USA).
+ Open protocol
+ Expand
7

Multiparametric Flow Cytometry for Immune Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immune-monitoring studies, patient PBMC samples were stained with cocktail fluorescent-conjugated antibody mix diluted in PBS containing 2% FBS + 0.01% azide for 30 min at 4 °C in the dark. After a 2-step washing with PBS, cells were fixed with 2% PFA for 20 min at 4 °C. Samples were analyzed on a BD Fortessa Flow Cytometer (UV-Violet-Blue-Yellow/Green-Red 5-Laser configuration). For the first cohort (aviremic patients) the following antibodies were used: CCR5-FITC, CD158a-PE, CD57-PE-CF594, CD14-Alexa Fluor 700, CD19-Alexa Fluor 700, CXCR4-BV421, CD62L-BV605, NKG2D-BV650, CD16-BV711, CD3-BV786, CD56-BUV395 and CD4-BUV737 (BD Biosciences), CD158b-PE, CD158e/k-PE, NKp46-PE-Vio770, NKG2C-APC, CD45RA-APC-Vio770, and CD45RO-VioGreen (Miltenyi). For the second cohort (viremic patients) the similar panel of antibodies were re-used, except for additional antibodies for CXCR4-BV421 and CD107a-PE-CF594 (BD Biosciences). Cell death and viability were determined by DAPI (BD Biosciences). Data were analyzed using FlowJo software (v10.8) (BD Biosciences) with appropriate plugins for high-dimensional analysis and visualization.
+ Open protocol
+ Expand
8

Antigen-specific T cell responses post-PCV13 vaccination

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antigen specific responses were analyzed ex-vivo by measuring the co-expression of the activation markers CD25/OX40 and CD25/PDL1 [23 , 24 (link)] and T-follicular helper cell (Tfh) markers on CD4 T cells (CXCR5+PD1+). Cryopreserved PBMC from d0, 7, and 14 post PCV13 vaccination were thawed and stimulated with PCV13 (2.5μg/ml) or SEB (1μg/ml) in the absence of Golgi-inhibitors for 18–24hrs. Cells were stained with LIVE/DEAD fixable blue dye as above and surface stained with CD4-Qdot655 (ThermoFisher), CD3-APC eFluor 780 (ThermoFisher), OX40-PECy7 (Biolegend), CD8-AlexaFluor 700, CD14-AlexaFluor 700, CD19-AlexaFluor 700, CD45RA-450, CCR7-PercpCy5.5, CD25-FITC, PDL1-PE, CXCR5-Brilliant Violet 510, and PD1-APC (all BD Biosciences). Cells were fixed and analyzed on an LSRII as described above.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!